Deep Track Capital, LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Syros Pharmaceuticals, Inc. (SYRS)

Filing Manager: Deep Track Capital, LP
Reporting Manager: Deep Track Capital, LP
Security: Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value
Symbol: SYRS
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 08:41 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Deep Track Capital, LP	0%	0	0	0	/s/ David Kroin	David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd.	0%	0	0	0	/s/ David Kroin	David Kroin, Director
David Kroin	0%	0	0	0	/s/ David Kroin	David Kroin